We are all talking about localising the production and procurement of immunisation supplies. The disparity of the distribution of immunisation supplies associated with manufacturing capacity has indeed stood out globally, since the outbreak of the COVID-19 pandemic. Producing vaccines locally may offer increased autonomy and improved vaccine security, but requires skilled technicians, stringent regulatory oversight and lengthy timelines. Governments also need a deep understanding of markets, demand and supply levers, regulatory requirements and manufacturing processes to initiate and/ or scale local immunisation supplies procurement.
To better understand the challenges of localisation and learn from peers who have chosen to manufacture vaccines locally, join us on Tuesday, 20 May, at 10am GMT+2, for the first webinar in this new VPPN series. The event will focus on local vaccine manufacturing, thanks to the contributions of government partners from Egypt and South Africa and the expertise of the Clinton Health Access Initiative (CHAI).
The webinar will be held in English, Arabic, French and Russian and take place on Zoom, on Tuesday, 20 May 2025, from 10am to 11.05am GMT+2. To take part in it, you need to register here. Please, note that registration is compulsory and that, once registered, you will receive an e-mail confirmation with the link to the webinar.
Are you also planning to manufacture vaccines? Do not hesitate to share any question or concern you have on the subject. A 15-minute Q&A session will be included in the webinar, and our panellists and experts will be happy to answer you with their experience and insight.
Please find below all relevant details on this webinar and the whole series. We are looking forward to welcoming you during this event. And in the meantime, you can reach me, through the platform or by email at [email protected], for any request or question you might have.
Kind regards,
Dyuti
*****
Objectives
Outline the historical and emerging objectives of local vaccine manufacturing
Provide an overview of the key components needed to create an enabling environment for local vaccine manufacturing
Discuss key common challenges faced with countries when creating the enabling environment, and share respective experiences and lessons learned
Answer questions on the topic
Speakers
Subject-matter expert: • Mohammed Badat, Senior Associate, Vaccine Markets, Clinton Health Access Initiative (CHAI) Egypt: • Mostafa Ghorab, Business Development Director, The Egyptian Authority for Unified Procurement • Rania Mohsen, Project Management Department Director, The Egyptian Authority for Unified Procurement South Africa: • Marione Schonfeldt, Senior Pharmaceutical Policy Specialist, National Department of Health Moderator: • Kristina Lorenson, Senior Contracts Manager, Vaccine Centre, UNICEF
Agenda
10:00am GMT+2 Welcome and introduction of the topic 10:03am GMT+2 CHAI presentation 10:18am GMT+2 Egypt's presentation 10:33am GMT+2 South Africa's presentation 10:48am GMT+2 Questions & Answers 11:03am GMT+2 Closing remarks
